Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on: August 28,2024

Immune landscape and response to oncolytic virus-based immunotherapy

by Frontiers JournalsCredit:Frontiers of Medicine(2024). DOI: 10.1007/s11684-023-1048-0Oncolytic virus (OV)-based immunotherapy has emerged as a promising strategy for cancer treatment, of

Updated on:August 28,2024

Genomic features of AML in patients over age 60 can predict success of stem cell transplant

by Dana-Farber Cancer InstituteR. Coleman Lindsley, MD, PhD. Credit: Dana-Farber Cancer InstituteFor older patients with acute myeloid leukemia (AML), the prospects for success of a stem cell tra

Updated on: March 14,2024

Genomic features of AML in patients over age 60 can predict success of stem cell transplant

by Dana-Farber Cancer InstituteR. Coleman Lindsley, MD, PhD. Credit: Dana-Farber Cancer InstituteFor older patients with acute myeloid leukemia (AML), the prospects for success of a stem cell tra

Updated on:March 14,2024

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on: March 30,2024

Immunotherapy targeting cancer fusion protein may hold key to treating rare liver cancer

by St. Jude Children's Research HospitalCredit: Unsplash/CC0 Public DomainFibrolamellar carcinoma (FLC) is a rare liver cancer with a poor prognosis if not addressed early with surgery. The d

Updated on:March 30,2024

Doctors and molecular engineers working to enlist the immune system to fight cancer

by Sharla A. Paul,University of ChicagoT cells attacking cancer. Credit: royaltystockphotoWhen telling the story of immunotherapy and cancer and how the two battle it out, it's awfully chall

Updated on: May 17,2024

Doctors and molecular engineers working to enlist the immune system to fight cancer

by Sharla A. Paul,University of ChicagoT cells attacking cancer. Credit: royaltystockphotoWhen telling the story of immunotherapy and cancer and how the two battle it out, it's awfully chall

Updated on:May 17,2024

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the

Updated on: September 25,2024

New study explores challenges and opportunities for cancer research

by Richard Harth,Arizona State UniversityA recent review by Carlo Maley, a researcher at Arizona State University, and Lucie Laplane from the University of Paris Pantheon-Sorbonne critiques the

Updated on:September 25,2024

Safer, swifter, smaller scar: New brain surgery approach targets difficult tumors at skull base

Updated on: July 05,2024

Safer, swifter, smaller scar: New brain surgery approach targets difficult tumors at skull base

Updated on:July 05,2024

Small molecule drug reverses ADAR1-induced cancer stem cell cloning capacity

byUniversity of California - San DiegoA colorized scanning electron micrograph depicts human red blood cells. Credit: UC San Diego Health SciencesResearchers at University of California San Dieg

Updated on: January 11,2024

Small molecule drug reverses ADAR1-induced cancer stem cell cloning capacity

byUniversity of California - San DiegoA colorized scanning electron micrograph depicts human red blood cells. Credit: UC San Diego Health SciencesResearchers at University of California San Dieg

Updated on:January 11,2024

Clues found regarding tumor suppressor gene's breast cancer activity

byJohns Hopkins University School of MedicineCredit: Saraswati Sukumar and Priya PaiResearchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress fo

Updated on: January 21,2024

Clues found regarding tumor suppressor gene's breast cancer activity

byJohns Hopkins University School of MedicineCredit: Saraswati Sukumar and Priya PaiResearchers at the Johns Hopkins Kimmel Cancer Center have revealed how the gene HOXA5 may work to suppress fo

Updated on:January 21,2024

Multiple recurrent, repeat expansions found in human cancer genomes

by Bob Yirka , Medical XpressGenome-wide detection of rREs in cancer genomes. a, Scheme of the method to identify rREs in 2,509 patients across 29 human cancer types: 1, head and neck squamous cell ca

Updated on: February 18,2024

Multiple recurrent, repeat expansions found in human cancer genomes

by Bob Yirka , Medical XpressGenome-wide detection of rREs in cancer genomes. a, Scheme of the method to identify rREs in 2,509 patients across 29 human cancer types: 1, head and neck squamous cell ca

Updated on:February 18,2024

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Updated on: February 23,2024

Researchers synthesize chimeric peptide that elicits antitumor activity for cancer immunotherapy

by Science China PressThepeptide Pal-DMPOP consists a peptide inhibitor of CD47/SIRPα, a D-peptide inhibitor of PD-1/PD-L1, and a palmitic acid tail conjugated at its N-terminal through a P

Updated on:February 23,2024

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on: January 15,2024

New drug delays progression of glioma, a deadly brain cancer, during clinical trial

by Denise Heady,University of California, Los AngelesCredit: Unsplash/CC0 Public DomainIn an international study co-led by UCLA, scientists have shown that a new targeted therapy drug can extend

Updated on:January 15,2024

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

Updated on: February 01,2024

New study highlights rapid adoption of clinical research results into chemotherapy prescribing patterns

by National Comprehensive Cancer NetworkCredit: Pixabay/CC0 Public DomainNew research inJNCCN—Journal of the National Comprehensive Cancer Networkevaluates how an important analysis on loc

Updated on:February 01,2024